Clonidine and cardiac surgery: haemodynamic and metabolic effects, myocardial ischaemia and recovery. 1999

P S Myles, and J O Hunt, and H O Holdgaard, and R McRae, and M R Buckland, and J Moloney, and J Hall, and M A Bujor, and D S Esmore, and B B Davis, and D J Morgan
Department of Anaesthesia, Alfred Hospital, Melbourne, Victoria.

Clonidine may have beneficial effects in patients undergoing major surgery. We enrolled 156 patients having elective CABG surgery in a double-blind, randomized trial. Patients were randomized to receive either two doses of placebo (Group PP) or clonidine 5 micrograms/kg (Group CC). Perioperative measurements included haemodynamics, anaesthetic and analgesic drug usage, creatinine clearance, cortisol excretion, recovery times and quality of life (SF-36) after surgery. Overall, there was no significant difference with time to tracheal extubation (median [10-90 centile]): CC 7.1 (3.4-18) h vs PP 8.0 (4.3-17) h, P = 0.70; but there was a higher proportion of patients extubated within four hours: CC 20% vs. PP 8%, P = 0.038. Clonidine resulted in a number of significant (P < 0.05) haemodynamic changes, particularly pre-CPB: less tachycardia and hypertension, more bradycardia and hypotension. Clonidine was associated with a significant (P < 0.05) reduction in anaesthetic drug usage, higher creatinine clearance, lower cortisol excretion and improvement in some aspects of quality of life. This study lends support to consideration of clonidine therapy in patients undergoing CABG surgery.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007431 Intraoperative Complications Complications that affect patients during surgery. They may or may not be associated with the disease for which the surgery is done, or within the same surgical procedure. Peroperative Complications,Surgical Injuries,Complication, Intraoperative,Complication, Peroperative,Injuries, Surgical,Complications, Intraoperative,Complications, Peroperative,Injury, Surgical,Intraoperative Complication,Peroperative Complication,Surgical Injury
D008297 Male Males
D010101 Oxygen Consumption The rate at which oxygen is used by a tissue; microliters of oxygen STPD used per milligram of tissue per hour; the rate at which oxygen enters the blood from alveolar gas, equal in the steady state to the consumption of oxygen by tissue metabolism throughout the body. (Stedman, 25th ed, p346) Consumption, Oxygen,Consumptions, Oxygen,Oxygen Consumptions
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D011788 Quality of Life A generic concept reflecting concern with the modification and enhancement of life attributes, e.g., physical, political, moral, social environment as well as health and disease. HRQOL,Health-Related Quality Of Life,Life Quality,Health Related Quality Of Life
D003000 Clonidine An imidazoline sympatholytic agent that stimulates ALPHA-2 ADRENERGIC RECEPTORS and central IMIDAZOLINE RECEPTORS. It is commonly used in the management of HYPERTENSION. Catapres,Catapresan,Catapressan,Chlophazolin,Clofelin,Clofenil,Clonidine Dihydrochloride,Clonidine Hydrochloride,Clonidine Monohydrobromide,Clonidine Monohydrochloride,Clopheline,Dixarit,Gemiton,Hemiton,Isoglaucon,Klofelin,Klofenil,M-5041T,ST-155,Dihydrochloride, Clonidine,Hydrochloride, Clonidine,M 5041T,M5041T,Monohydrobromide, Clonidine,Monohydrochloride, Clonidine,ST 155,ST155
D003404 Creatinine Creatinine Sulfate Salt,Krebiozen,Salt, Creatinine Sulfate,Sulfate Salt, Creatinine
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked

Related Publications

P S Myles, and J O Hunt, and H O Holdgaard, and R McRae, and M R Buckland, and J Moloney, and J Hall, and M A Bujor, and D S Esmore, and B B Davis, and D J Morgan
June 1994, Canadian journal of anaesthesia = Journal canadien d'anesthesie,
P S Myles, and J O Hunt, and H O Holdgaard, and R McRae, and M R Buckland, and J Moloney, and J Hall, and M A Bujor, and D S Esmore, and B B Davis, and D J Morgan
January 1981, British journal of pharmacology,
P S Myles, and J O Hunt, and H O Holdgaard, and R McRae, and M R Buckland, and J Moloney, and J Hall, and M A Bujor, and D S Esmore, and B B Davis, and D J Morgan
June 1991, Lancet (London, England),
P S Myles, and J O Hunt, and H O Holdgaard, and R McRae, and M R Buckland, and J Moloney, and J Hall, and M A Bujor, and D S Esmore, and B B Davis, and D J Morgan
October 1987, Herz,
P S Myles, and J O Hunt, and H O Holdgaard, and R McRae, and M R Buckland, and J Moloney, and J Hall, and M A Bujor, and D S Esmore, and B B Davis, and D J Morgan
December 2014, British journal of anaesthesia,
P S Myles, and J O Hunt, and H O Holdgaard, and R McRae, and M R Buckland, and J Moloney, and J Hall, and M A Bujor, and D S Esmore, and B B Davis, and D J Morgan
January 1978, Archives internationales de pharmacodynamie et de therapie,
P S Myles, and J O Hunt, and H O Holdgaard, and R McRae, and M R Buckland, and J Moloney, and J Hall, and M A Bujor, and D S Esmore, and B B Davis, and D J Morgan
November 1984, British heart journal,
P S Myles, and J O Hunt, and H O Holdgaard, and R McRae, and M R Buckland, and J Moloney, and J Hall, and M A Bujor, and D S Esmore, and B B Davis, and D J Morgan
January 1983, Clinical and experimental pharmacology & physiology,
P S Myles, and J O Hunt, and H O Holdgaard, and R McRae, and M R Buckland, and J Moloney, and J Hall, and M A Bujor, and D S Esmore, and B B Davis, and D J Morgan
January 2006, European journal of nuclear medicine and molecular imaging,
P S Myles, and J O Hunt, and H O Holdgaard, and R McRae, and M R Buckland, and J Moloney, and J Hall, and M A Bujor, and D S Esmore, and B B Davis, and D J Morgan
October 1966, Lancet (London, England),
Copied contents to your clipboard!